151 related articles for article (PubMed ID: 31729192)
1. Systemic biomarkers of allogeneic haematopoietic stem cell transplantation outcome-Brief introduction.
Mrazek F
HLA; 2019 Dec; 94 Suppl 2():25-29. PubMed ID: 31729192
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Aladağ Karakulak E; Demİroğlu H; Malkan UY; Akman U; Göker H; Büyükaşik Y
Turk J Med Sci; 2021 Feb; 51(1):355-358. PubMed ID: 32927932
[TBL] [Abstract][Full Text] [Related]
3. Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation.
Dander E; De Lorenzo P; Bottazzi B; Quarello P; Vinci P; Balduzzi A; Masciocchi F; Bonanomi S; Cappuzzello C; Prunotto G; Pavan F; Pasqualini F; Sironi M; Cuccovillo I; Leone R; Salvatori G; Parma M; Terruzzi E; Pagni F; Locatelli F; Mantovani A; Fagioli F; Biondi A; Garlanda C; Valsecchi MG; Rovelli A; D'Amico G
Oncotarget; 2016 Dec; 7(50):82123-82138. PubMed ID: 27893415
[TBL] [Abstract][Full Text] [Related]
4. Profile of Inflammation-Associated Proteins in Early Post-Transplant Samples of Patients After Allogeneic Hematopoietic Stem Cell Transplantation: a Preliminary Study.
Mrazek F; Schneiderova P; Kriegova E; Raida L; Kuba A; Gajdos P; Königova N; Onderkova J; Ambruzova Z
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):55-61. PubMed ID: 28083617
[TBL] [Abstract][Full Text] [Related]
5. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
Levine JE; Braun TM; Harris AC; Holler E; Taylor A; Miller H; Magenau J; Weisdorf DJ; Ho VT; Bolaños-Meade J; Alousi AM; Ferrara JL;
Lancet Haematol; 2015 Jan; 2(1):e21-9. PubMed ID: 26687425
[TBL] [Abstract][Full Text] [Related]
6. Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.
Paczesny S
Br J Haematol; 2021 Mar; 192(6):951-967. PubMed ID: 32039480
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.
Fowler DH; Foley J; Whit-Shan Hou J; Odom J; Castro K; Steinberg SM; Gea-Banacloche J; Kasten-Sportes C; Gress RE; Bishop MR
Clin Gastroenterol Hepatol; 2004 Mar; 2(3):237-45. PubMed ID: 15017608
[TBL] [Abstract][Full Text] [Related]
9. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Lee KH; Choi SJ; Lee JH; Lee JS; Kim WK; Lee KB; Sohn SK; Kim JG; Kim DH; Seol M; Lee YS; Lee JH
Haematologica; 2005 Jul; 90(7):939-48. PubMed ID: 15996932
[TBL] [Abstract][Full Text] [Related]
11. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
12. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
[TBL] [Abstract][Full Text] [Related]
13. Plasma biomarkers in graft-versus-host disease: a new era?
Paczesny S; Levine JE; Braun TM; Ferrara JL
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):33-8. PubMed ID: 19147075
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for Allogeneic HCT Outcomes.
Adom D; Rowan C; Adeniyan T; Yang J; Paczesny S
Front Immunol; 2020; 11():673. PubMed ID: 32373125
[TBL] [Abstract][Full Text] [Related]
15. Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation.
Chen S; Zeiser R
Front Immunol; 2020; 11():1854. PubMed ID: 33013836
[TBL] [Abstract][Full Text] [Related]
16. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
Vander Lugt MT; Braun TM; Hanash S; Ritz J; Ho VT; Antin JH; Zhang Q; Wong CH; Wang H; Chin A; Gomez A; Harris AC; Levine JE; Choi SW; Couriel D; Reddy P; Ferrara JL; Paczesny S
N Engl J Med; 2013 Aug; 369(6):529-39. PubMed ID: 23924003
[TBL] [Abstract][Full Text] [Related]
17. Advances in predicting acute GVHD.
Harris AC; Ferrara JL; Levine JE
Br J Haematol; 2013 Feb; 160(3):288-302. PubMed ID: 23205489
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of biomarkers associated with acute and chronic graft versus host disease.
Ahmed SS; Wang XN; Norden J; Pearce K; El-Gezawy E; Atarod S; Hromadnikova I; Collin M; Holler E; Dickinson AM
Bone Marrow Transplant; 2015 Dec; 50(12):1563-71. PubMed ID: 26367225
[TBL] [Abstract][Full Text] [Related]
19. Changes in protein serum levels during stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; Corrente F; Piccirillo N; Bacigalupo AP; Sica S; Chiusolo P
Eur J Clin Invest; 2017 Oct; 47(10):711-718. PubMed ID: 28796281
[TBL] [Abstract][Full Text] [Related]
20. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
Qayed M; Kapoor U; Gillespie S; Westbrook A; Aguayo-Hiraldo P; Ayuk FA; Aziz M; Baez J; Choe H; DeFilipp Z; Etra A; Grupp SA; Hexner E; Holler E; Hogan WJ; Kowalyk S; Merli P; Morales G; Nakamura R; Pulsipher MA; Schechter T; Shah J; Spyrou N; Srinagesh HK; Wölfl M; Yanik G; Young R; Kitko CL; Ferrara JLM; Levine JE
Transplant Cell Ther; 2024 Jun; 30(6):603.e1-603.e11. PubMed ID: 38548227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]